Relationship
type: Class

Grant
type: Class

Anualidad
type: Class

Continuant
type: Class

Entity
type: Class

2024
type: Class

2023
type: Class

Specifically Dependent Continuant
type: Class

RDF description of http://research.umh.es/vivo/pub/proyecto/KERNPHARMA122A
type: Document
rights: termsOfUse
date: 2026-08-28T11:33:26
publisher: KERNPHARMA122A

Investigator on KERNPHARMA122A
type: Entity
type: InvestigatorRole
type: BFO_0000017
type: Thing
type: Specifically Dependent Continuant
type: BFO_0000023
type: Continuant
BFO_0000054: KERNPHARMA122A
type: ResearcherRole
related by: KERNPHARMA122A

Investigator on KERNPHARMA122A
type: ResearcherRole
type: Thing
BFO_0000054: KERNPHARMA122A
type: Entity
type: BFO_0000023
type: Continuant
type: Specifically Dependent Continuant
related by: KERNPHARMA122A
type: InvestigatorRole
type: BFO_0000017

GONZALEZ ALVAREZ, MARIA ISABEL
type: PersonActive
type: Agent
type: Entity
type: Person
type: Thing
type: BFO_0000004
type: Continuant
related by: KERNPHARMA122A

Optimización Biofarmacéutica y disolución biopredictiva 2023
type: ResearchOrganizationReport
type: Anualidad
type: Thing
type: ResearchReport
type: 2023
includes: KERNPHARMA122A

Ingeniería 2024
type: Anualidad
type: 2024
type: DepartmentReport
type: Thing
type: ResearchReport
includes: KERNPHARMA122A

Ingeniería 2023
type: Anualidad
type: DepartmentReport
type: Thing
type: ResearchReport
type: 2023
includes: KERNPHARMA122A

Principal Investigator on KERNPHARMA122A
type: Thing
type: PrincipalInvestigatorRole
type: BFO_0000023
type: BFO_0000017
related by: KERNPHARMA122A
BFO_0000054: KERNPHARMA122A
type: ResearcherRole
type: Specifically Dependent Continuant
type: Entity
type: InvestigatorRole
type: Continuant

GONZALEZ ALVAREZ, MARTA
type: PersonActive
type: Agent
type: Entity
type: Person
type: Thing
type: BFO_0000004
type: Continuant
related by: KERNPHARMA122A

BERMEJO SANZ, MARIA DEL VAL
type: PersonActive
type: Agent
type: Entity
type: Person
type: Thing
type: BFO_0000004
type: Continuant
related by: KERNPHARMA122A

Optimización Biofarmacéutica y disolución biopredictiva 2024
type: ResearchOrganizationReport
type: Anualidad
type: 2024
type: Thing
type: ResearchReport
includes: KERNPHARMA122A